CTOs on the Move

National Hospice Medical Equipment

www.nationalhme.com

 
National HME is accredited by HQAA for Hospice Medical Equipment Services, as well as Clinical Respiratory Services. * National HME provides equipment for hospice patients 24/7 at no additional cost to the hospice program. * National HME provides simplified billing allowing your program more time to devote to patient care while reducing the hassle of HME bill reconciliation. Most contracts offered to hospice programs promote all-inclusive packaging with minimal extra charges allowing you the peace of mind that comes with understanding the exact cost for HME. * National HME maintains a minimal amount of warehoused equipment to streamline and work efficiently in ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million

Executives

Name Title Contact Details
Mike Tarpley
Vice President and Chief Technology Officer Profile

Similar Companies

Trumpf Medical Systems

Trumpf Medical Systems is a Charleston, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Maddak

Maddak is a Pequannock, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Zap Surgical Systems

Leveraging unique gyroscopic motion, ZAP-X® opens new frontiers in modern radiosurgery. Combining self-shielding technology with high dose rate linear-accelerator delivery, ZAP-X was created to safely treat more patients in more places.

C-MIX

C-MIX is a Delray Beach, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Becton Dickinson

BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery` diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology` services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 65`000 employees have a passion and commitment to help improve patient outcomes` improve the safety and efficiency of clinicians` care delivery process` enable laboratory scientists to better diagnose disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers` BD can help enhance outcomes` lower costs` increase efficiencies` improve safety and expand access to health care. In 2017` BD welcomed C. R. Bard and its products into the BD family.